Abridge Secures $250M Series D Funding and Launches AI Engine

Abridge has raised $250 million in Series D funding, announced in a press release. The investment round was co-led by Elad Gil and IVP, with participation from notable investors such as Bessemer Venture Partners, CapitalG, and NVIDIA's NVentures. This funding will support the development of Abridge's AI capabilities and commercial growth.
In addition to the funding announcement, Abridge has introduced a new Contextual Reasoning Engine. This AI architecture is designed to produce clinically useful and billable notes at the point of care, addressing the issue of incomplete clinical notes that delay billing processes. The engine integrates data from past patient encounters and health system-specific guidelines to create comprehensive notes, simplifying revenue cycle workflows.
Abridge's platform is now deployed in over 100 health systems, including major institutions like Duke Health, Johns Hopkins, and Mayo Clinic. The company aims to reduce administrative burdens and improve patient care by enabling clinicians to focus more on their patients rather than documentation.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Funding
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more